Related Experiment Video
Updated: Aug 19, 2026

10:32
Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model
Published on: April 2, 2021
Fulminate type of retinopathy of prematurity
Parag K Shah1, V Narendran, V R Saravanan
1Department of Vitreous & Retina, Aravind Eye Hospital, Coimbatore, India.
Indian Journal of Ophthalmology
|February 8, 2005
Insights
Routine screening for retinopathy of prematurity (ROP) starting at 2 weeks of age is crucial for early detection and treatment of severe ROP cases.
Area of Science:
- Ophthalmology
- Neonatal care
Background:
- Retinopathy of prematurity (ROP) is a significant cause of visual impairment in premature infants.
- Early detection and intervention are critical to prevent severe visual outcomes.
Observation:
- Ophthalmoscopic screening is the standard method for ROP diagnosis.
- Screening typically commences around 2 weeks of age for at-risk infants.
Findings:
- Routine screening from 2 weeks of age is necessary.
- This schedule aids in identifying fulminant ROP, a rapidly progressing form of the disease.
Implications:
- Timely detection allows for prompt treatment, potentially preventing blindness.
- Establishing consistent screening protocols is vital for neonatal eye care.
Abstract:
Routine ophthalmoscopic screening for retinopathy of prematurity (ROP) from the age of 2 weeks is necessary to detect and treat fulminate ROP.
Related Concept Videos
Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
The Retina
The retina is a layer of nervous tissue at the back of the eye that transduces light into neural signals. This process, called phototransduction, is carried out by rod and cone photoreceptor cells in the back of the retina.
Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...

